Tom Dubin

Tom Dubin is a pharmaceutical executive and attorney. From 2001 through 2013 he was the Chief Legal Officer and a member of the core executive team that grew Alexion Pharmaceuticals from the development stage to membership in the S&P 500. At Alexion, Tom led legal, government affairs, pricing and reimbursement, corporate communications, and other functions, and held commercial responsibility for the company’s Australasia region. Prior to Alexion, Tom served as Vice President and General Counsel of ChiRex, Inc., an international corporation providing advanced process development services and specialty manufacturing to the pharmaceutical industry. Tom began his career as a corporate attorney with Cravath, Swaine & Moore in New York City. He is a past Director of BioBlast Pharmaceuticals (NASD: ORPN), a member of the advisory board of Mythic Pharmaceuticals, a Trustee of American Jewish World Service, and Vice-Chair of Norwalk Hospital, and a member of Yale School of Public Health’s Leadership Council. He received his J.D. from New York University School of Law, his M.P.H. from Yale University, and his B.A. from Amherst College, cum laude.